SAFE-GUARD- fenbendazole suspension 
Schering Corporation

----------

safe-guard®
(fenbendazole)
Dewormer

INDICATIONS:

Goats - 2.3 mg/lb (5 mg/kg) body weight for the treatment and control of:

Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

DIRECTIONS: Administer orally. The recommended dose of 2.3 mg/lb (5 mg/kg) is achieved when 2.3 mL of the drug are given for each 100 lb body weight.

Dosing Examples for Goats:

Body WeightAmount
25 lb0.6 mL
50 lb1.2 mL
75 lb1.7 mL
100 lb2.3 mL
125 lb2.9 mL

Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

Fenbendazole (active ingred.) made in China. Formulated in France.

WARNINGS: NOT FOR USE IN HUMANS. KEEP OUT OF REACH OF CHILDREN. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or http://www.fda.gov/reportanimalae.

OTHER WARNINGS: Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

Store at or below 25°C (77°F). Protect from freezing. Shake well before use.

Restricted drug (California) - Use only as directed.

Distributed by: Intervet Inc
(d/b/a Merck Animal Health)

Madison, NJ 07940 ©2020 Intervet Inc.,
a subsidiary of Merck & Co. Inc.

LOT NO:

EXP
DATE:

Rev. 09/20

Approved by FDA under
NADA # 128-620

387770 R11

PRINCIPAL DISPLAY PANEL - 125 mL Bottle Label

safe-guard®
(fenbendazole)

Dewormer
for Goats

Suspension 10%
(100mg/mL)

Withdrawal Periods and Residue
Warnings: Goats must not be
slaughtered for human consumption
within 6 days following treatment.
Because a milk discard time has
not been established, do not use
in lactating goats.

Consult your veterinarian for
assistance in the diagnosis, treatment
and control of parasitism.

MERCK
Animal Health

125 mL (4.2 fl oz)

368607 R6

PRINCIPAL DISPLAY PANEL - 125 mL Bottle Label
SAFE-GUARD 
fenbendazole suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:57926-089
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Fenbendazole (UNII: 621BVT9M36) (Fenbendazole - UNII:621BVT9M36) Fenbendazole100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
methylparaben (UNII: A2I8C7HI9T)  
propylparaben (UNII: Z8IX2SC1OH)  
silicon dioxide (UNII: ETJ7Z6XBU4)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
povidone, unspecified (UNII: FZ989GH94E)  
trisodium citrate dihydrate (UNII: B22547B95K)  
citric acid monohydrate (UNII: 2968PHW8QP)  
water (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57926-089-01125 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA12862009/20/1983
Labeler - Schering Corporation (001317601)
Establishment
NameAddressID/FEIBusiness Operations
Intervet Production S.A.771867553MANUFACTURE
Establishment
NameAddressID/FEIBusiness Operations
Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd420823163API MANUFACTURE

Revised: 9/2021
Document Id: 51fba1b5-0dca-483a-ba37-58bd62bb4a32
Set id: 89567dad-e2d5-4b7b-9e6e-c35668c3c2fa
Version: 4
Effective Time: 20210913
 
Schering Corporation